Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams

Pharmazie

Volumn 62, Issue 7, 2007, Pages 505-509

  Souto, E B ^a   Müller, Rainer H ^a,b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b PharmaSol GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CLOTRIMAZOLE; DYNASAN 116; FUNGIZID; SOLID LIPID NANOPARTICLE; TRIPALMITIN; TYLOXAPOL; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CREAM; DERMATOMYCOSIS; DERMATOPHYTE; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG FORMULATION; DRUG RELEASE; FLOW KINETICS; HYDROPHILICITY; IN VITRO STUDY; PARTICLE SIZE; SHEAR RATE; SHEAR STRESS; SPECTROPHOTOMETER; TINEA; ULTRAVIOLET SPECTROPHOTOMETRY;

ALGORITHMS; ANTIFUNGAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CLOTRIMAZOLE; EMULSIONS; LIPIDS; NANOPARTICLES; OINTMENTS; PARTICLE SIZE; REFERENCE STANDARDS; RHEOLOGY; SOLUBILITY;

EID: 34447515830     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.7.5205     Document Type: Article

References (22)

1. Dingier, A (1998) Feste Lipid-Nanopartikel als kolloidale Wirkstoffträger-systeme zur dermalen Applikation. PhD Thesis. Berlin, Freie Universität Berlin.
2. Försyer AH, Herrington TM (1997) Rheology of siloxane-stabilized water in silicone emulsions. Int J Cosmet Sci 19: 173-191.
3. Franz TJ (1975) Percutaneous absorption on the relevance of in vitro data. Invest Dermatol 64: 190-195.
4. Greenberg HL, Shwayder TA, Bieszk N, Fivenson DP (2002) Clotrimazole/betamethasone dipropionate: A review of costs and complications in the treatment of common cutaneous fungal infections. Ped Dermatol 19: 78-81.
5. Henry KW, Nickels JT, Edlind TD (2000) Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 44: 2693-2700.
6. Higuchi T (1961) Rate of release of medicaments from ointment bases containing drags in suspension. J Pharm Sci 50: 874-875.
7. Higuchi T (1963) Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52: 1145-1149.
8. Jenning V, Hildebrand GE, Gysler A, Schäfer-Korting M, Gohla S (1999) Solid lipid nanoparticles (SLN) for topical application: occlusive properties. Proc Intern Symp Control Rel Bioact Mater 26: 405-406.
9. Jenning V, Schäfer-Korting M, Gohla S (2000) Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release 66: 115-126.
10. Junginger HE (1992) Systematik der Dermatika - Kolloidchemischer Aufbau, in Niedner R, Ziegenmeyer J (eds): Dermatika Stuttgart, Wissenschaftliche Verlagsgesellschaft mbH.
11. Kast CE, Valenta C, Leopold M, Bernkop-Schnürch A (2002) Design and in vitro evaluation of a novel bioadhesive vaginal drag delivery system for clotrimazole. J Control Release 81: 347-354.
12. Maia CS, Mehnert W, Schläfer-Korting M (2000) Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm 196: 165-167.
13. Mehnert W, Mäder K (2001) Solid lipid nanoparticles - Production, characterization and applications. Adv Drag Deliv Rev 47: 165-196.
14. Mei Z, Chen H, Weng T, Yang Y, Yang X (2003) Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 56: 189-196.
15. Müller RH, Heinemann S (1993) Fat emulsions for parenteral nutrition. II. Characterization and physical stability of Lipofundin MCT/LCT Clin Nutrition 12: 298-309.
16. Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drag delivery - A review of the state of art. Eur J Pharm Biopharm 50: 161-177.
17. Müller RH, Mehnert W, Souto EB (2005) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for dermal delivery, in: Bronaugh L: Percutaneous Absorption. New York, Basel, Hong-Kong, Marcel Dekker, Inc.: 719-738.
18. Müller RH, Radtke M, Wissing SA (2002) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54: S131-S155.
19. Vazquez JA (2000) Therapeutic options for management of oropharyngeal and esophageal candidiasis in HTV/ATDS patients. HJV Clin. Trials 1: 47-59.
20. Westesen K, Bunjes H, Koch MHJ (1997) Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release 48: 223-236.
21. Wissing SA, Lippacher A, Müller RH (2001) Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J Cosmet Sci 52: 313-324.
22. Wissing SA, Müller RH (2003) Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm 254: 65-68.